chromolaena odorata/抗真菌药

An aqueous ethanol extract of leaves of Chromolaena odorata and some of its fractions were examined for their antifungal properties by dilution methods on solid and liquid media, using yeasts and filamentous fungi. Extract and fractions inhibit the in vitro growth of Cryptococcus neoformans,

BACKGROUND Chromolaena odorata (L.) R.M. King & H. Rob. (Asteraceae) is a scrambling perennial shrub that originated in the Americas, but is now common in sub-Saharan Africa, Asia and Oceania, where it has become a serious weed. The species, particularly the biotype found in Asia and West Africa,

Peroxisome proliferator-activated receptors (PPARs) are key regulators of lipid and glucose metabolism and have become important therapeutic targets for various diseases. The phytochemical investigation of the chloroform-soluble extract of Chromolaena odorata led to the isolation of a PPAR-gamma

Long-term exposure to high glucocorticoid levels induces memory impairment and neurodegeneration in Alzheimer's disease (AD) by increasing the expression of amyloid β and tau hyperphosphorylation (pTau). Previous studies showed beneficial effects of flavonoids in neurodegenerative models.

Ethnopharmacological relevance: Myanmar's Mon people largely depend on a traditional medical system for health care, however, information about their medical plants is rare in the current literature. In this first ethnobotanical study of